TSEN2 Antibody

Code CSB-PA850858DSR2HU
Size US$166
Order now
Image
  • Western blot
    All lanes: TSEN2 antibody at 5μg/ml + 293T whole cell lysate
    Secondary
    Goat polyclonal to rabbit IgG at 1/10000 dilution
    Predicted band size: 54, 52, 50, 48, 46 kDa
    Observed band size: 54 kDa

  • Immunohistochemistry of paraffin-embedded human brain tissue using CSB-PA850858DSR2HU at dilution of 1:100

Have Questions? Leave a Message or Start an on-line Chat

Product Details

Full Product Name
Rabbit anti-Homo sapiens (Human) TSEN2 Polyclonal antibody
Uniprot No.
Target Names
TSEN2
Alternative Names
HsSen2 antibody; MGC2776 antibody; MGC4440 antibody; SEN2 antibody; SEN2_HUMAN antibody; SEN2L antibody; tRNA intron endonuclease Sen2 antibody; tRNA splicing endonuclease 2 homolog (SEN2; S. cerevisiae) antibody; tRNA splicing endonuclease subunit Sen2 antibody; tRNA-intron endonuclease sen2 antibody; tRNA-splicing endonuclease subunit Sen2 antibody; TSEN 2 antibody; TSEN2 antibody
Raised in
Rabbit
Species Reactivity
Human
Immunogen
Recombinant Human tRNA-splicing endonuclease subunit Sen2 protein (1-220AA)
Immunogen Species
Homo sapiens (Human)
Conjugate
Non-conjugated
Clonality
Polyclonal
Isotype
IgG
Purification Method
Antigen Affinity Purified
Concentration
It differs from different batches. Please contact us to confirm it.
Buffer
PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
Form
Liquid
Tested Applications
ELISA, WB, IHC
Recommended Dilution
Application Recommended Dilution
WB 1:200-1:1000
IHC 1:50-1:200
Troubleshooting and FAQs
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time
Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
Constitutes one of the two catalytic subunit of the tRNA-splicing endonuclease complex, a complex responsible for identification and cleavage of the splice sites in pre-tRNA. It cleaves pre-tRNA at the 5'- and 3'-splice sites to release the intron. The products are an intron and two tRNA half-molecules bearing 2',3'-cyclic phosphate and 5'-OH termini. There are no conserved sequences at the splice sites, but the intron is invariably located at the same site in the gene, placing the splice sites an invariant distance from the constant structural features of the tRNA body. Isoform 1 probably carries the active site for 5'-splice site cleavage. The tRNA splicing endonuclease is also involved in mRNA processing via its association with pre-mRNA 3'-end processing factors, establishing a link between pre-tRNA splicing and pre-mRNA 3'-end formation, suggesting that the endonuclease subunits function in multiple RNA-processing events. Isoform 2 is responsible for processing a yet unknown RNA substrate. The complex containing isoform 2 is not able to cleave pre-tRNAs properly, although it retains endonucleolytic activity.
Involvement in disease
Pontocerebellar hypoplasia 2B (PCH2B)
Subcellular Location
Nucleus. Nucleus, nucleolus. Note=May be transiently localized in the nucleolus.
Protein Families
TRNA-intron endonuclease family
Tissue Specificity
Isoform 1 and isoform 2 are widely expressed at very low level.
Database Links

HGNC: 28422

OMIM: 608753

KEGG: hsa:80746

STRING: 9606.ENSP00000284995

UniGene: Hs.335550

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Place an order now

I. Product details

*
*
*
*

II. Contact details

*
*

III. Ship To

*
*
*
*
*
*
*

IV. Bill To

*
*
*
*
*
*
*
*